Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1448)	12/30/2002 11:03:58 PM
From: Judi Simpson	Read Replies (1) \| Respond to of 1477

Nice article in this morning's San Jose Mercury about Scios.

To: Biomaven who wrote (1448)	2/7/2003 1:27:44 PM
From: Ausdauer	Read Replies (1) \| Respond to of 1477

Maven, I suspect JNJ is interested in the arthritis drug. Increasing Natrecor sales are a plus, but the sales projections for 2007 don't spell blockbuster. Message 17469138 The outpatient market may prove to be a large one and chronic subcutaneous infusions may also boost sales beyond expectations. An acquaintance suggested that an arthritis drug if the pipeline, along with better than expected Natrecor sales has probably increased speculation in SCIOS's stock to the current level. Aus